
Laboratory + Life Sciences Architecture
We recognize the importance and value of life sciences as building blocks of growth, knowledge and innovation. Providing bespoke architectural design is essential to their successful practice and critically important discoveries.
Designed with Flexibility
Distinguishing ourselves by bringing innovative thinking to all our projects, Pickard Chilton is often selected for projects featuring the latest cutting-edge technology of today and anticipating flexibility for the future. Flexible laboratory spaces are designed to allow for cost-effective modifications, easy reconfigurations, and multi-functional capabilities to maximize real estate usage, create savings, and minimize the risks of space dependency regarding expensive laboratory equipment and necessary building systems.
A Climate for Discovery
Many of the spaces we are designing today for our clients feature flexible, dynamic spaces that foster a culture experimentation, innovation, and interdisciplinary investigation. Integration of laboratory spaces within the context of a collaborative workplace has become a growing trend. Generating an influx of incubator-style laboratories, employees are attracted to a balanced office culture experience that provides access to the highly sophisticated environment of the laboratory integrated with premier workspaces and the latest amenities.

Boston Properties has begun building an apartment tower that will become Cambridge's tallest building even as the region faces a construction slowdown.
The project is part of a $1.2B redevelopment and partnership with Eversource that will include not only the residential tower but also two life sciences buildings and an underground substation, the Boston Business Journal reported.
The 16-story life sciences buildings at 290 and 300 Binney St. total 810K SF and are 100% pre-leased to AstraZeneca and the Broad Institute. In November, BXP sold a 45% stake in the life sciences buildings to Norges Bank Investment Management in a deal that values them at $1.7B.